Responses
Endometrial cancer
2022-RA-702-ESGO Real-world treatment patterns and outcomes in recurrent or advanced endometrial cancer patients initiating 1st-line systemic therapy in Europe: a retrospective chart review study
Compose a Response to This Article
Other responses
No responses have been published for this article.